empagliflozin
eli lilly,Boehringer Ingelheim
['heart failure']
on-call and just catching up on #esccongress amazing that we have a treatment that reduces risk of:
- hospitalised heart failure
- cv death
- kidney failure requiring dialysis or transplantation *irrespective* of:
- lvef
- albuminuria (tbc, eagerly awaiting empa-kidney) 
Academic nephrology registrar, @Oxford_NDPH & @GeorgeInstitute trained trialist, identifying & implementing new ways to reduce kidney & cardiovascular risk